Here we present a system in which metastatic cancer cells release a cell-penetrating fluorescent protein, which is taken up by neighbouring cells and enables spatial identification of the local metastatic cellular environment. Using this system, tissue cells with low representation in the metastatic niche can be identified and characterized within the bulk tissue. To highlight its potential, we applied this strategy to study the cellular environment of metastatic breast cancer cells in the lung. We report the presence of cancer-associated parenchymal cells, which exhibit stem-cell-like features, expression of lung progenitor markers, multi-lineage differentiation potential and self-renewal activity. In ex vivo assays, lung epithelial cells acquire a cancer-associated parenchymal-cell-like phenotype when co-cultured with cancer cells and support their growth. These results highlight the potential of this method as a platform for new discoveries.
Direct investigation of the early cellular changes induced by metastatic cells within the surrounding tissue remains a challenge.
Here we present a system in which metastatic cancer cells release a cell-penetrating fluorescent protein, which is taken up by neighbouring cells and enables spatial identification of the local metastatic cellular environment. Using this system, tissue cells with low representation in the metastatic niche can be identified and characterized within the bulk tissue. To highlight its potential, we applied this strategy to study the cellular environment of metastatic breast cancer cells in the lung. We report the presence of cancer-associated parenchymal cells, which exhibit stem-cell-like features, expression of lung progenitor markers, multi-lineage differentiation potential and self-renewal activity. In ex vivo assays, lung epithelial cells acquire a cancer-associated parenchymal-cell-like phenotype when co-cultured with cancer cells and support their growth. These results highlight the potential of this method as a platform for new discoveries.
Cancer cell behaviour is strongly influenced by the surrounding cells in the tumour microenvironment (TME). Various cell types in the TME are known to influence cancer cell behaviour, including mesenchymal cells such as activated fibroblasts, pericytes and endothelial cells, as well as different types of inflammatory cells 1 .
During the early phase of metastatic growth, cancer cells generate a local TME (metastatic niche), which is distinct from the normal tissue structure and key for supporting metastatic outgrowth 2 . However, detailed analysis of the cellular composition of the metastatic niche, especially at early stages, is constrained by the difficulty of spatially discriminating the metastatic-niche cells within the bulk tissue. This hampers the identification of cells that might respond to early colonization by cancer cells but remain low in number as metastases grow.
In this study, we present a strategy in which metastatic cancer cells mark their neighbouring cells, thereby identifying them in the tissue and overcoming these limitations. We have applied this system to interrogate the early metastatic environment of breast cancer cells in the lung. We confirm that the system enables us to quantitatively and qualitatively distinguish known metastatic-niche cells within the tissue, and identify lung epithelial cells, in which a regenerative-like program is activated, as a component of the metastatic TME. We show that these epithelial cells acquire multi-lineage differentiation potential when co-cultured with cancer cells and support their growth. These results support the notion that, in addition to the well-characterized stromal activation, a parenchymal response might contribute to creating the metastatic microenvironment.
The mCherry niche-labelling system
To develop a labelling system that uses metastatic cancer cells to directly identify their neighbouring cells in vivo, we generated a secreted fluorescent mCherry protein containing a modified lipid-permeable transactivator of transcription (TATk) peptide 3, 4 (sLP-mCherry) ( Fig. 1a and Extended Data Fig. 1a ). We engineered 4T1 breast cancer cells to co-express the sLP-mCherry and GFP; we refer to these cells as labelling-4T1 cells. In vitro, sLP-mCherry protein secreted by labelling-4T1 cells re-enters the cells, as indicated by changes in the intracellular localization of the red fluorescence (Extended Data Fig. 1b, c) . sLP-mCherry protein is also taken up by unlabelled cells, both in co-culture with labelling-4T1 cells ( Fig. 1b-d ) and when cultured in medium conditioned by labelling-4T1 cells (LCM) (Extended Data Fig. 1d, e ). Upon uptake into a cell, sLP-mCherry fluorescence has an intracellular half-life of 43 h (Extended Data Fig. 1f ) and is localized in CD63 + multi-lamellar bodies (lysosomal-like structures) where, owing to its high photostability 5 , it retains high fluorescence intensity (Extended Data Fig. 1g, h ). Fractionation of LCM shows that only the soluble fraction retains labelling activity, whereas the extracellular vesicles, a proportion of which contain sLP-mCherry, do not show labelling activity in vitro (Extended Data Fig. 1i-k) .
In vivo, intravenous injection of labelling-4T1 cells (GFP + mCherry + ) into syngeneic BALB/c mice to induce lung metastases efficiently labels surrounding host tissue cells (GFP − mCherry + ), penetrating approximately five cell layers ( Fig. 1e -g and Extended Data Fig. 2a, b ). This enables specific discrimination of host cells in close proximity to cancer cells from distal lung cells (GFP − mCherry − ) using fluorescenceactivated cell sorting (FACS) ( Fig. 1f ). Notably, when micro-metastases grow larger, the number of mCherry + -niche cells in the tissue remains proportional to the number of metastatic cells (Extended Data Fig. 2c ). We detected no adaptive immunogenicity against sLP-mCherry and the local increase of CD45 + immune cells within the mCherry population was observed specifically as a response to cancer cells (Extended Data Fig. 2d −f). Thus, this mCherry-niche-marking strategy enables spatial reconstitution of the local metastatic niche within the tissue. This permits functional identification of labelled cells and direct comparison with unlabelled cells within the same lung.
Tissue spatial resolution
To demonstrate the utility of the mCherry-niche strategy to specifically interrogate the local early changes induced by cancer cells, we Article reSeArcH seeded 4T1-labelling cells in the lung via tail-vein injection. Lung tissue distant from micro-metastases remained unperturbed by primarytumour-derived systemic changes 7 . To validate the mCherry-niche strategy, we first examined components known to be involved in metastatic-niche formation. CD45 + immune cells were very abundant in the mCherry + niche and nearly exclusively derived from the myeloid lineage (CD11b + ) (Extended Data Figs. 2d, 3a). Lung neutrophils have been reported to enhance metastatic growth of cancer cells 8, 9 , and were indeed detected in the mCherry + niche (Extended Data Fig. 3b ). Because abnormalities in lung neutrophils are often associated with cancer 10 , we isolated mCherry + -niche neutrophils (Ly6G + ) and compared their proteome to that of unlabelled neutrophils from the same lungs ( Fig. 2a ). The sub-pool of mCherry + -niche neutrophils exhibited an increase in translation, oxidative phosphorylation and intracellular reactive oxygen species (ROS) levels relative to unlabelled neutrophils, as determined by FACS analysis (Fig. 2b , Extended Data Fig. 3c-f and Supplementary Data). To validate the functional relevance of specific features identified in mCherry + -niche cells, we developed a 3D-scaffold co-culture system that mimics complex tissue-like cell-cell interactions. We found that lung neutrophils increased growth of actin-GFP + mouse mammary tumour virus (MMTV)-polyoma virus middle T antigen (PyMT) breast cancer cells in a ROS-dependent manner ( Fig. 2c -e and Extended Data Fig. 3g , h). Collectively, these data highlight the potential of our strategy to detect in vivo changes that are spatially restricted to the metastatic environment.
The non-immune mCherry + -niche signature
Whereas the contribution of immune cells to metastatic outgrowth has been widely investigated 11 , less is known about the role of other TME cell types during metastatic nesting. Notably, the mCherry-labelling strategy can be used to provide spatiotemporal information by applying it to different stages of metastatic progression. We generated the gene-expression profile of non-immune (CD45 − ) mCherry + -niche cells at the time point immediately preceding micro-metastases as well as at an advanced metastatic stage ( Fig. 3a, b ). The majority of alterations were detected at the early stage, but additional changes subsequently discriminated the niche of macro-metastases ( Fig. 3c and Extended Data Fig. 4a, b ), confirming the evolution of the metastatic TME over time. MetaCore dataset enrichment and gene-set enrichment analysis (GSEA) highlighted changes in pathways related to proliferation, inflammation and tissue remodelling (Extended Data Fig. 4b, c ). We next focused on the upregulated (more than twofold) genes encoding soluble factors in the mCherry + niche at both time points ( Fig. 3d and Supplementary Data). We found many previously reported tumour-promoting factors [12] [13] [14] [15] [16] [17] [18] [19] , further validating the ability of our labelling system to faithfully capture the in vivo metastatic niche. We also found WNT1-induced protein (WISP1)-which has been suggested to act as an oncogene in breast cancer 20 -to be widely expressed in the mCherry + niche (Fig. 3d ). Indeed, we detected upregulation of WISP1 in both cancer and metastatic-niche cells and confirmed its pro-metastatic activity by exogenous inhibition in vivo ( Fig. 3e and Extended Data Fig. 5a -e). We next probed the TME for other non-immune cell types, which might be difficult to resolve by standard techniques owing to their small numbers. Of note, we found pathways associated with lung epithelial cells in the metastatic-niche signature ( Fig. 3f ). Micro-metastases grow embedded within the alveolar compartment of the lung, and we found alveolar type II cells (AT2) expressing surfactant protein C (SP-C, encoded by Sftpc) in the metastatic niche ( Fig. 3g ). We also found mCherry + -niche cells expressing the epithelial cell adhesion marker EPCAM, further supporting the presence of cells of lung parenchymal origin ( Fig. 3h , i).
Cancer-associated parenchymal cells
We found mCherry + -niche epithelial cells to have a higher proliferative activity compared to their normal lung counterparts ( Fig. 4a ). Concordantly, we detected alveolar cell clusters with increased proliferative activity at the metastatic borders of human breast cancer lung metastases, suggesting that a lung parenchymal response to metastatic growth may occur in both mouse and human (Extended Data Fig. 6a -f). Cancer cells benefit from the presence of a lung parenchymal response, as freshly isolated EPCAM + cells from naive lungs supported the growth of actin-GFP + MMTV-PyMT tumour cells in our 3D-scaffold co-culture system ( Fig. 4b-d ). Moreover, in line with the results shown in Fig. 2c -e, the presence of both lung neutrophils and epithelial cells further enhanced tumour growth (Extended Data Fig. 7a-d ), highlighting the cellular complexity of the metastatic niche.
We next aimed to better define the perturbation occurring in lung epithelial cells in the proximity of cancer cells. To contextualize their presence among the other cellular components of the metastatic niche, we performed single-cell RNA sequencing (scRNA-seq) of CD45 − cells. t-Distributed stochastic neighbour embedding (t-SNE) analysis of mCherry + -niche cells identified a large stromal cluster in which different stromal cells could be distinguished ( Fig. 4e and Extended Data Fig. 8a-c ). This is in agreement with the various known mesenchymal cell components of the TME, as well as the characterization of different fibroblast subsets [21] [22] [23] [24] . Notably, specifically in the mCherry + niche, Epcam-expressing epithelial cells are distributed in two clusters distinguished by the expression of E-cadherin (Cdh1) ( Fig. 4e ). We found that only mCherry + -niche Epcam + Cdh1 + cells shared the expression of alveolar genes 25 with unlabelled distant lung Epcam + cells ( Fig. 4f, g) . Conversely, mCherry + -niche Epcam + Cdh1 − cells expressed both the progenitor markers SCA1 (encoded by Ly6a) and Tm4sf1 [26] [27] [28] (Fig. 4g ). As validation of this de-differentiated signature observed in the majority of epithelial cells in the metastatic niche, reverse transcription with quantitative PCR (RT-qPCR) of EPCAM-sorted mCherry + -niche cells also showed an overall reduction in expression of alveolar lineage Article reSeArcH markers ( Fig. 4h ). Moreover, the enrichment of EPCAM + SCA1 + cells in the mCherry + niche of different metastatic cell types was confirmed by FACS analysis ( Fig. 4i and Extended Data Fig. 9a-c) . Similarly, the presence of epithelial cells expressing another lung progenitor marker, integrin β4 (also known as CD104) 29 , was increased in the mCherry +niche and in ex vivo co-cultures (Extended Data Fig. 9d-i) .
In summary, we describe a parenchymal response to lung metastasis involving de-differentiated pools of epithelial cells in the niche, which we define as cancer-associated parenchymal cells (CAPs).
CAPs are activated AT2 cells
To functionally characterize CAPs, we tested their lineage differentiation potential ex vivo using a 3D Matrigel-based organoid co-culture system 27 (Fig. 5a ). Unlabelled resident lung EPCAM + cells are predominantly alveolar 27 , and formed mainly alveolar organoids when co-cultured with CD31 + cells ( Fig. 5b-d ). mCherry + -niche EPCAM + cells favoured the bronchiolar lineage and showed a remarkable capacity to generate multi-lineage bronchioalveolar organoids (Fig. 5d ). Despite the bias in organoid formation towards the bronchial lineage, we did not detect mCherry-labelled cells expressing bronchial markers in vivo (Extended Data Fig. 10a ). CAPs also retained high self-renewal capacity over multiple passages (Fig. 5e ).
Next, we tested whether tumour cells could directly induce the CAP phenotype. When EPCAM + cells from unlabelled distal micrometastatic lungs or naive lungs were co-cultured with metastatic cells, they generated a higher proportion of bronchiolar and bronchioalveolar organoids ( Fig. 5f -h and Extended Data Fig. 10b , c). Similar alterations were induced by cancer cells when the assay was performed using mouse lung fibroblasts (MLg cells) instead of CD31 + cells (Extended Data Fig. 10b, c) .
Although lung EPCAM + cells are predominantly alveolar, they also contain epithelial progenitors that could be enriched by cancer cells to generate increased plasticity 27, 30 . Therefore, we performed organoid cultures using lineage-labelled AT2 (Sftpc-lineage) cells. Sftpc-lineage cells, which show no plasticity in co-culture with CD31 + cells, generated multi-lineage bronchioalveolar organoids when exposed to cancer cells, supporting the idea of a reprogramming activity driven by cancer-cell-derived factors ex vivo ( Fig. 5i, j) . Despite the potential of cancer cells to modulate the organoid formation ability of lineage-labelled club cells (Scgb1a1 lineage), only rare single Scgb1a1-lineage cells were found in proximity to lung metastases (Extended Data Fig. 10d-f ). Conversely, metastases growing in Sftpc-lineage lungs demonstrated the alveolar (AT2) origin of the CAPs (Fig. 5k) .
Recently, a rare population of AT2 cells expressing Axin2 with stem cell and repair activity (AT2 stem cells), was described in the lung alveoli 31 . Whereas a small proportion of Axin2-expressing cells was found in the unlabelled epithelial cluster, Axin2 was undetectable in the mCherry + -niche EPCAM clusters (data not shown). Therefore, even if cancer cell seeding could trigger lung injury, this phenomenon does not appear to specifically maintain an Axin2 + AT2 population in the metastatic niche.
Collectively, these data demonstrate the alveolar origin of CAPs and the ability of cancer cells to induce multi-lineage differentiation potential of epithelial cells ex vivo.
Discussion
This study introduces the mCherry-niche labelling system and demonstrates its ability to resolve the host tissue cellular environment in regions surrounding cancer cells. We report the presence of a lung epithelial compartment within the metastatic niche, which originates from AT2 cells. We define this TME component as CAPs and describe their activated regenerative state by showing their de-differentiated signature, tissue stem-cell-like features, multi-lineage differentiation potential and increased self-renewal activity.
Parenchymal cells have been described as triggering a tissue-wide pro-tumorigenic inflammatory response to systemic primary tumour signals 32, 33 . In addition to these systemic effects, we here show that a regenerative-like activation in the lung parenchyma occurs as a direct local response during breast cancer metastasis. This parenchymal response, combined with the stromal activation, is potentially a key orchestrator of tumour-niche formation.
Together these results consolidate the mCherry-niche system as a platform for discoveries with the potential to identify, isolate and functionally test cells from the metastatic niche with high spatial resolution.
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Methods
Sample sizes were estimated based on previous experiments conducted in our laboratory, providing sufficient numbers of mice in each group to yield a twosided statistical test, with the potential to reject the null hypothesis with a power (1 − β) of 80%, subject to α = 0.05. No further statistical methods were used to predetermine sample size. Most experiments were not randomized: only the experiment involving treatment was randomized. Whenever possible, investigators were blinded to allocation during outcome assessment. Statistical analysis. Statistical analyses were performed using Prism v.7.0c (GraphPad Software). P values were obtained from two-tailed Student's t-tests with paired or unpaired adjustment. When needed, unpaired t-tests were adjusted using Welch's correction for unequal variance. In one instance (Fig. 4i ), data in one of the groups did not pass the D' Agostino and Pearson normality test, therefore a Wilcoxon matched-pairs signed-rank test was performed. Single-sample tests were also used for comparisons of co-cultured cancer cell growth on scaffolds to the normalized value of cancer cells alone. For comparisons between two scaffold conditions of growth over time or to perform multiple analysis between experimental groups, two-way ANOVA was used. Mouse strains. All mice used are available from the Jackson Laboratory. MMTV-PyMT mice 34 are on a FVB and C57BL/6 background, actin-GFP mice 35 and Rag1 KO mice are on the FVB background (gift from J. Huelsken laboratory (EPFL, Lausanne, Switzerland)). Sftpc-Cre ERT236 , Rosa26R-YFP 37 (Sftpc-Cre ERT2 ;R26R-YFP) mice are on a C57BL/6 background. BALB/cJ mice and the above-mentioned lines were bred and maintained under specific-pathogen-free conditions by The Francis Crick Biological Research Facility and female mice were used between 6 and 10 weeks of age. Breeding and all animal procedures were performed at the Francis Crick Institute in accordance with UK Home Office regulations under project license P83B37B3C.
For ex vivo organoid lineage-tracing experiments, Scgb1a1-Cre ERT2 and Rosa26R-fGFP 38 , Sftpc-Cre ERT2 (Sftpc-Cre ERT2 ;R26R-fGFP and Scgb1a1-Cre ERT2 ;R26R-fGFP) mice on a C57BL/6 background were bred and maintained under specific-pathogen-free conditions at the Gurdon Institute of the University of Cambridge in accordance with UK Home Office project licence PC7F8AE82. All animal work was conducted under UK Home Office regulations, project licenses P83B37B3C and PC7F8AE82. Tamoxifen administration. Tamoxifen (Merck Sigma-Aldrich) was dissolved in Mazola corn oil (Merck Sigma-Aldrich) in a 20 mg ml −1 stock solution. Two doses of tamoxifen (0.2 mg per g body weight) were given via oral gavage every other day and lung tissues were collected two days after tamoxifen administration to isolate cells for lung organoids. For in vivo lineage tracing three doses of tamoxifen (0.2 mg per g body weight) were given via oral gavage over consecutive days and mice were injected two weeks later. Cells. MLg cells were purchased from ATCC. Cancer-associated fibroblasts (CAFs) isolated from MMTV-PyMT tumours and human normal fibroblasts (hNLFs) were a gift from E. Sahai. MMTV-PyMT cells were isolated from MMTV-PyMT tumours as previously described 19 . All other cell lines were provided by the Cell Services Unit of The Francis Crick Institute. All cell lines were authenticated and tested for mycoplasma by the Cell Services Unit of The Francis Crick Institute. MMTV-PyMT cells were cultured on collagen-solution-coated dishes in DMEM/F12 (Thermo Fisher Scientific) with 2% fetal bovine serum (FBS; Labtech), 100 U ml −1 penicillin-streptomycin (Thermo Fisher Scientific), 20 ng ml −1 EGF (Thermo Fisher Scientific) and 10 μg ml −1 insulin (Merck Sigma-Aldrich). The collagen solution was made with 30 μg ml −1 PureCol collagen (Advanced Biomatrix), 0.1% bovine serum albumin (BSA), 20 mM HEPES in HBSS (Thermo Fisher Scientific). HC11 cells were cultured in RPMI (Thermo Fisher Scientific) supplemented with 10% FBS, 100 U ml −1 penicillinstreptomycin, 10 ng ml −1 EGF (Thermo Fisher Scientific) and 5 μg ml −1 insulin. All other cell lines were cultured in DMEM (Thermo Fisher Scientific) supplemented with 10% FBS and 100 U ml −1 penicillin-streptomycin. All cells were cultured at 37 °C and 5% CO 2 . Human samples. Human pulmonary breast cancer metastases from independent patients were obtained from the Grampian Biorepository, Aberdeen Royal Infirmary (REC approval: 16/NS/0055). Four samples were stained by immunohistochemistry and immunofluorescence and proliferation of epithelial cells was quantified. Further information about the human samples used is provided in the Supplementary Information. Labelling system. A soluble peptide (SP) 3 and a modified TAT peptide 4 were cloned upstream of the mCherry cDNA, under the control of a mouse PGK promoter (sLP-mCherry, see Supplementary Data for sequence). The sLP-mCherry sequence was cloned into a pRRL lentiviral backbone. 4T1, Renca, CT26 and HC11 cells were stably infected with sLP-mCherry and pLentiGFP lentiviral particles and subsequently sorted to isolate mCherry + GFP + cells. Induction of experimental metastases. Procedures were performed at the Francis Crick Institute in accordance with UK Home Office regulations under project license P83B37B3C. Cancer cells were injected intravenously to generate metastases in the lung: 4T1 (1,000,000), Renca (500,000) or CT26 (200,000) cells were resuspended in 100 μl PBS and injected into the tail vein of BALB/cJ mice. Mice were euthanized on the basis of a time period rather than on the basis of their clinical signs. Therefore, the experimental end point (time controlled, seven days unless otherwise specified) most likely occurred before a humane end point (as determined by deterioration of heath conditions). All animals were monitored daily for unexpected clinical signs following the P83B37B3C licence guidelines and the principles set out in the NCRI Guidelines for the Welfare and Use of Animals in Cancer Research (UK). Deterioration of health conditions-such as reduction in food and water consumption, changes in the general appearance of the animal, or weight loss of 10% over a 24-h period-would result in animals being euthanized before the experimental end point. In vivo lineage-tracing experiments. Sftpc-Cre ERT2 and Scgb1a1-Cre ERT2 mice on a C57BL/6 background were injected into the tail vein with 175,000 MMTV-PyMT C57BL/6 cells and lungs were collected 4 weeks later, or with 700,000 E0771 cells and lungs were collected 12 days later. Tissue digestion for cell isolation or analysis. Lung tissues were dissociated as previously described 19 . In brief, lungs were removed at day 7 after tumour cell injection (unless otherwise specified), minced manually and then digested for 30 min in a shaker at 37 °C with a mixture of DNase I (Merck Sigma-Aldrich) and Liberase TM and TH (Roche Diagnostics) in HBSS solution. Samples were then washed, passed through a 100-μm filter and incubated in Red Blood Cell Lysis buffer (Miltenyi Biotec) for 3-5 min at room temperature. After a wash with MACS buffer (0.5% BSA and 250 mM EDTA in PBS), samples were passed through a 40-μm filter and a 20-μm strainer-capped flow cytometry tube to generate a single-cell suspension to use for flow cytometric analysis or further purification. FACS analysis and cell sorting. Prepared single-cell suspensions of mouse lung tissues and in vitro cell lines were incubated with mouse FcR Blocking Reagent (Miltenyi Biotec) for 10 min at 4 °C followed by an incubation with a mix of pre-labelled antibodies (antibody information is provided in the Supplementary Information) for 30 min at 4 °C. After two washes with MACS buffer, dead cells were stained with DAPI. Flow cytometry analyses were carried out on a BD LSR-Fortessa (BD Biosciences) and FlowJo v.10.4.2 (FlowJo, LCC 2006-2018) was used for further analysis. All cell-sorting experiments were carried out using a BD Influx cell sorter (BD Biosciences).
Tissue digestion and FACS analysis in ex-vivo lineage-tracing experiments.
Lung tissues were dissociated with a collagenase-dispase solution as previously described 27 . In brief, after lungs were cleared by perfusion with cold PBS through the right ventricle, 2 ml dispase (50 U ml −1 , BD Biosciences) was instilled into the lungs through the trachea until the lungs inflated, followed by instillation of 1% low melting agarose (Bio-Rad Laboratories) through the trachea to prevent leakage of dispase. Each lobe was dissected and minced into small pieces in a conical tube containing 3 ml PBS, 60 μl collagenase-dispase (Roche) and 7.5 μl of 1% DNase I (Merck Sigma-Aldrich) followed by rotating incubation for 45 min at 37 °C. The cells were then filtered sequentially through 100-and 40-μm strainers and centrifuged at 1,000 r.p.m. for 5 min at 4 °C. The cell pellet was resuspended in 1 ml of ACK lysis buffer (0.15 M NH 4 Cl, 10 mM KHCO 3 , 0.1 mM EDTA) and lysed for 90 s at room temperature. Six millilitres of basic F12 medium (Thermo Fisher Scientific) was added and 500 μl FBS (Fisher Scientific) was slowly added in the bottom of the tube. Cells were centrifuged at 1,000 r.p.m. for 5 min at 4 °C. The cell pellet was resuspended in PF10 buffer (PBS with 10% FBS) for further staining. The antibodies used were as follows: CD45 (30-F11)-APC (BD Biosciences), CD31 (MEC13.3)-APC (BD Biosciences) and EPCAM (G8.8)-PE-Cy7 (BioLegend). For antibody list see Supplementary Information. The MOFLO system (Beckman Coulter) was used for the sorting at Wellcome-MRC Stem Cell Institute Flow Cytometry Facility. Lung organoid assay. Lung organoid co-culture assays were previously reported 27, 39 . In brief, freshly sorted epithelial cells (EPCAM + CD45 − CD31 − Ter119 − GFP − ) from either the metastatic niche or the distal lung were resuspended in 3D basic medium (DMEM/F12, supplemented with 10% FBS, penicillin-streptomycin, 1 mM HEPES and insulin-transferrin-selenium (ITS) (Merck Sigma-Aldrich), and mixed with MACS-sorted CD31 + lung stromal cells or MLg cells followed by resuspension in growth factor-reduced (GFR) Matrigel (BD Biosciences) at a ratio of 1:1. One hundred microlitres of mixture was then placed in a 24-well transwell insert with a 0.4-μm pore (Corning). Distal lung or niche epithelial cells (10 3 to 2.5 × 10 3 cells) and 25,000 CD31 + or MLg cells were seeded in each insert. Five hundred microlitres of 3D basic medium was placed in the lower chamber and medium was changed every other day. In addition, freshly sorted Scgb1a1-lineage labelled cells or Sftpc-lineage labelled cells were resuspended in 3D basic medium followed by mixing with GFR Matrigel retaining CD31 + stromal cells as described above. For co-culture of lung epithelial cells with tumour cells, a mixture of 10 3 to 2.5 × 10 3 distal lung epithelial cells and 25,000
Article reSeArcH CD31 + cells in Matrigel was placed in the Transwell insert, and 2,000 tumour cells were FACS-sorted from metastatic lungs and seeded in the lower chamber. Plates were scored for colony number after 14 days. Organoid-forming efficiency was calculated as the number of organoids formed per number of cells plated per well as a percentage. Quantification of distinct types of differentiated organoids was performed by scoring the organoids expressing SOX2 or SP-C and HOPX by immunofluorescence from at least five step sections (20 μm apart) per individual well. Bright-field images were acquired after 14 days using an EVOS microscope (Thermo Fisher Scientific). 3D cell culture. Primary MMTV-PyMT actin-GFP cells were seeded at a density of 5,000 cells per well in a collagen-solution-coated Alvetex Scaffold 96-well plate (ReproCELL). The following day, Ly6G + lung cells and/or Epcam + lung epithelial cells were sorted by MACS and seeded on top of the cancer cells at a density of 50,000 cells per well. In selected experiments, wells were supplemented with 4-hydroxy-TEMPO (200 μM, Merck Sigma-Aldrich) or mouse WISP1 antibody (250 ng ml −1 , MAB1680, R&D Systems). The growth of GFP + cells was monitored daily for 6 days using the SteREO LumarV12 stereomicroscope (Zeiss), and images were quantified using ImageJ (NIH). For quantification, the Li's minimum cross entropy thresholding algorithm was performed on the stacked images.
For the CD104 staining experiment, EPCAM + lung cells were sorted from mouse lung tissues by MACS and seeded at a density of 1,500,000 cells per well on collagen-solution-coated Alvetex Scaffold 12-well inserts. After 48 h, MMTV-PyMT actin-GFP cells were seeded on top of the EPCAM + cells at a density of 2,000 cells per scaffold insert. Immunofluorescence and immunohistochemistry. Mouse lungs were fixed in 4% PFA in PBS for 24 h and embedded in paraffin blocks. Four-micrometre-thick tissue sections were cut, deparaffinized and rehydrated using standard methods. After heat-mediated antigen retrieval in citrate buffer (unless stated otherwise), sections were blocked with a solution of 1% BSA, 10% donkey serum in PBS. For antibody list, see Supplementary Information. mCherry and GFP staining. An overnight incubation at 4 °C with goat GFP and rabbit mCherry antibodies was followed by 1 h incubation at room temperature with anti-goat Alexa Fluor 488-and anti-rabbit Alexa Fluor 555-conjugated antibodies (1:400; Thermo Fisher Scientific). Next, the slides were incubated with Sudan Black B for 20 min and mounted with Vectashield mounting medium with DAPI (Vector Laboratories). Lineage staining. An overnight incubation at 4 °C with goat GFP antibody was followed by 45-min incubation at room temperature with secondary biotinylated antibodies. Next, the Vectastain Elite ABC kit (Vector Laboratories) was used according to the manufacturer's instructions. Cell nuclei were visualized with haematoxylin and analysis was performed on a Nikon Eclipse 90i light microscope and with NIS-elements software (Nikon). WISP1 staining. An overnight incubation at 4 °C with goat GFP and rabbit WISP1 antibodies was followed by 30-min incubation at room temperature with anti-goat Alexa Fluor 488 and anti-rabbit Alexa Fluor 555 (1:500; Thermo Fisher Scientific). Next, the slides were incubated with Sudan Black B for 20 min and mounted with Vectashield mounting medium with DAPI (Vector Laboratories). Ki67 staining. EPCAM + CD45 − CD31 − Ter119 − GFP − cells were sorted from lung suspensions, plated on polylysine-coated glass coverslips for 15 min at room temperature and fixed in 4% PFA in PBS for 10 min. After fixation, cells were permeabilized with 0.1% Triton X-100 in PBS for 5 min and incubated with a blocking solution (1% BSA, 10% goat serum, 0.3 M glycine and 0.1% Tween-20 in PBS) for 1 h at room temperature. Next, cells were incubated overnight with a rabbit Ki67 antibody diluted in blocking solution followed by a 1 h incubation with a goat anti-rabbit Alexa Fluor 488 antibody (1:500; Thermo Fisher Scientific). Finally, cells were mounted with Vectashield mounting medium with DAPI for imaging. E-cadherin staining. CD49f + CD104 + CD45 − CD31 − Ter119 − GFP − cells were sorted from lung suspensions, cytospun on glass slides and fixed in 4% PFA in PBS for 10 min. Next, cells were permeabilized with 0.5% Triton X-100 for 30 min and incubated in blocking solution (4% BSA, 0.05% Tween-20 in PBS) for 45 min at room temperature. Then, cells were incubated with a rat E-cadherin antibody in blocking solution overnight at 4 °C followed by an incubation with a goat anti-rat Alexa Fluor 647 antibody (1:500; Thermo Fisher Scientific). Finally, cells were mounted with Vectashield mounting medium with DAPI for imaging. CD104 staining. EPCAM + cells were sorted by MACS and plated on Alvetex scaffold inserts as described above. Seven days after plating the whole scaffold was collected, washed with PBS and incubated in blocking solution (10% goat serum in PBS) for 1 h at room temperature. Next, the samples were incubated with a conjugated CD104-eFluor660 antibody (1:100 in PBS with 1:10 FcR blocking (Miltenyi Biotec)) for 1 h at room temperature. Then, the samples were fixed with 4% PFA in PBS for 10 min and mounted with Vectashield mounting medium with DAPI. Images were captured with the Axio Scan.Z1 slide scanner (Zeiss, Germany). Lung organoid staining. Cultured organoids were fixed with 4% PFA in PBS for 2-4 h at room temperature followed by immobilization with Histogel (Thermo Fisher Scientific) for paraffin embedding. At least five step sections (20 μm apart) per individual well were stained. Fluorescence images were acquired using a confocal microscope Leica TCS SP5 (Leica Microsystems). All the images were further processed with Fiji software. TTF1 and Ki67 co-staining. Target retrieval solution pH 9 (Agilent DAKO) was used for antigen retrieval. For histology, 1-h incubation at room temperature with mouse TTF1 antibody was followed by 45-min incubation at room temperature with secondary biotinylated antibodies. Next, the Vectastain Elite ABC kit (Vector Laboratories) was used according to the manufacturer's instructions. Cell nuclei were visualized with haematoxylin and analysis was performed on a Nikon Eclipse 90i light microscope and with NIS-elements software (Nikon). For immunofluorescence, 1 h incubation at room temperature with mouse TTF1 and rabbit Ki67 antibodies was followed by 45 min incubation at room temperature with anti-mouse Alexa Fluor 555 and anti-rabbit Alexa Fluor 488 (1:250; Thermo Fisher Scientific). Next, the slides were incubated with Sudan Black B for 20 min and mounted with Vectashield mounting medium with DAPI (Vector Laboratories).
All images were captured with a Zeiss Upright710 confocal microscope or a Zeiss Upright780 confocal microscope unless otherwise stated. RT-qPCR. RNA preparation was performed using the MagMax-96 Total RNA Isolation Kit (Thermo Fisher Scientific). cDNA synthesis was performed using a SuperScript III First-Strand Synthesis System (Thermo Fisher Scientific) according to the manufacturer's protocol. Quantitative real-time PCR samples were prepared with 50-100 ng total cDNA for each PCR reaction. The PCR, data collection and data analysis were performed on a 7500 FAST Real-Time PCR System (Thermo Fisher Scientific). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as an internal expression reference. A list of primers used can be found in the Supplementary Information. Anti-WISP1 treatment in vivo. BALB/cJ female mice (6-8 weeks old) were administered with WISP1 antibody or a control-IgG antibody (5 μg AF1680 and 5 μg MAB1680, R&D Systems) via intra-tracheal injection (50 μl per mouse). The following day, mice were intravenously injected with 250,000 4T1 cells. Anti-WISP1 or control-IgG treatment was repeated daily via a second intra-tracheal injection on day 4 and intra-peritoneal injections on days 2, 3, 5 and 6. Mice were collected 7 days after the first treatment and lungs were embedded, cut and stained with haemotoxylin and eosin (H&E). The lung metastatic burden was assessed by counting the number of metastases on four levels (100-μm intervals) from two lung lobes (n = 10 per group). EdU in vitro proliferation assay. MMTV-PyMT actin-GFP cells were seeded at a density of 10,000 cells per well into collagen-solution-coated six-well plates. The following day, Ly6G + lung cells and/or EPCAM + lung cells were sorted by MACS and added to the wells at a density of 100,000 cells per well. After 60 h, wells were supplemented with 20 μM EdU (5-ethynyl-2′-deoxyuridine). Cells were collected 6 h later and EdU incorporation was assessed using the Click-iT Plus EdU Flow Cytometry Assay Kit (Thermo Fisher Scientific), according to the manufacturer's instructions. Sample data were acquired on a BD LSR-Fortessa flow cytometer and analysed using FlowJo 10 software. Conditioned medium preparation and vesicle isolation. Labelling-4T1 cells were plated on 10-cm Petri dishes. When cells were 80% confluent, 10 ml DMEM with 10% FCS was added to be conditioned for 48 h. The conditioned medium preparation and vesicle isolation were performed as previously described 40 . In brief, the medium was collected and spun at 300g for 10 min. Next, the supernatant was collected and spun at 2,000g for 10 min. The supernatant after this second centrifugation was collected and used as conditioned medium. For vesicle isolation, the conditioned medium was subsequently ultracentrifuged at 10,000g for 30 min and at 100,000g for 70 min. The vesicle pellet at this stage was washed with PBS, spun at 100,000g for 70 min and resuspended again in PBS for in vitro uptake experiments. ImageStream analysis. Image stream analyses were carried out on an ImageStream Mark X II Imaging Flow Cytometer (Amnis Merck). The acquired data were analysed using IDEA software (Amnis Merck). Electron microscopy. Experiments were performed on glass bottom dishes with a numbered grid (MatTek) to enable subsequent location of the same cell imaged by confocal microscopy. After confocal imaging, cells were fixed in 8% formaldehyde in 0.1 M phosphate buffer (pH 7.4) added in equal quantities to cell medium for 15 min and then further fixed in 2.5% glutaraldehyde and 4% formaldehyde in 0.1 M phosphate buffer (pH 7.4) for 1 h and then processed using the National Center for Microscopy and Imaging Research protocol 41 . For transmission electron microscopy, 70-nm serial sections were cut using a UC6 ultramicrotome (Leica Microsystems) and collected on formvar-coated slot grids.
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Statistics
For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Give P values as exact values whenever suitable.
For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings
For hierarchical and complex designs, identification of the appropriate level for tests and full reporting of outcomes Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated Our web collection on statistics for biologists contains articles on many of the points above.
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Policy information about availability of computer code Data collection Ilaria Malanchi and Joo-Hyeon Lee Jun 12, 2019 Flow cytometry: samples were run on a BD 671 LSR-Fortessa (BD Biosciences, USA) using the BD FACSDiva software v8.0.1.
